Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.62 |
| ▸ | CDK2 | P24941 | 2/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | HSP90AB1 | P08238 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CDK1 | P06493 | 3/20 | 0.38 |
| ▸ | SYK | P43405 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | MAP3K5 | Q99683 | 1/20 | 0.37 |
| ▸ | XDH | P47989 | 1/20 | 0.37 |
| ▸ | PDE4A | P27815 | 1/20 | 0.36 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.36 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.36 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.36 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30523368 | 0.82 | CYP1A2 (0.65) | CYP1A2CDK2TSHRRECQLMAPT | |
| SCHEMBL30523383 | 0.82 | CYP1A2 (0.65) | CYP1A2CDK2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL30523426 | 0.82 | CYP1A2 (0.65) | CYP1A2CDK2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL30523391 | 0.82 | CYP1A2 (0.65) | CYP1A2CDK2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL30523416 | 0.82 | CYP1A2 (0.65) | CYP1A2CDK2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL9385851 | 0.82 | CYP1A2 (0.65) | CYP1A2CDK2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL30523393 | 0.80 | CYP1A2 (0.62) | CYP1A2CDK2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL29404312 | 0.79 | CYP3A4 (0.67) | CYP1A2CDK2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL101669 | 0.79 | CYP3A4 (0.67) | CYP1A2CDK2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL459276 | 0.77 | CYP1A2 (1.00) | CYP1A2CDK2CYP3A4CYP2D6TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250108007-A1 | LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2025-04-03 | — | — | US | disclosed |
| EP-4424670-A1 | LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2024-09-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250108007-A1 | LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION | CETP, NPC1, LCAT | CYP1A2 2501/4885CDK2 4458/4885CYP3A4 3088/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.